Abstract:Target deconvolution can help understand how compounds exert therapeutic effects and can accelerate drug discovery by helping optimise safety and efficacy, revealing mechanisms of action, anticipate off-target effects and identifying opportunities for therapeutic expansion. Chemoproteomics, a combination of chemical biology with mass spectrometry has transformed target deconvolution. This review discusses modification-free chemoproteomic approaches that leverage the change in protein thermodynamics induced by small molecule ligand binding. Unlike modification-based methods relying on enriching specific protein targets, these approaches offer proteome-wide evaluations, driven by advancements in mass spectrometry sensitivity, increasing proteome coverage and quantitation methods. Advances in methods based on denaturation/precipitation by thermal or chemical denaturation, or by protease degradation are evaluated, emphasising the evolving landscape of chemoproteomics and its potential impact on future drug-development strategies.

What problem does this paper attempt to address?

The paper primarily discusses the application of stability-based chemical proteomics methods in drug discovery, particularly how these methods help in target deconvolution. By combining chemical biology with mass spectrometry techniques, researchers have developed a series of new methods that do not require chemical modification of small molecule ligands. These methods can assess the changes in the thermodynamic properties of proteins after interaction with small molecules. Specifically, the paper details several methods: 1. **Thermal stability-based chemical proteomics methods**: These methods utilize the structural changes of proteins when heated. When small molecules bind to proteins, they alter the protein's melting temperature (Tm), which can be used to evaluate the interaction strength between drugs and target proteins and to identify unknown drug targets or off-target effects causing toxicity. The methods mentioned in the paper include: - Thermal Proteome Profiling across a temperature range (TPP-TR); - Isothermal Concentration Response (TPP-CCR); - Two-Dimensional Thermal Proteome Profiling (2D-TPP); - Isothermal Shift Assay (iTSA), etc. 2. **Limited proteolysis-based chemical proteomics methods**: These methods rely on the altered protease sensitivity of proteins after binding with small molecules, mainly including: - Drug Affinity Responsive Target Stability (DARTS); - Limited Proteolysis coupled with Mass Spectrometry (LiP-MS). These methods not only help in understanding how compounds exert therapeutic effects but also accelerate the drug discovery process, optimize drug safety and efficacy, reveal mechanisms of action, predict off-target effects, and identify opportunities for therapeutic expansion. Additionally, the paper discusses the advantages, limitations, and potential impacts of these methods in drug discovery strategies. In summary, the paper aims to address how chemical proteomics techniques can better elucidate drug mechanisms of action and proposes several new methods based on protein stability to achieve this goal.

Stability-based approaches in chemoproteomics

Chemoproteomics, A Broad Avenue to Target Deconvolution

Methods to Profile the Macromolecular Targets of Small Compounds.

Chemistry-based Functional Proteomics for Drug Target Deconvolution

Chemical Proteomics to Identify Molecular Targets of Small Compounds

Emerging opportunities for intact and native protein analysis using chemical proteomics

An immuno-chemo-proteomics method for drug target deconvolution

Biochemical Reactions in Metabolite-Protein Interaction

Chemoproteomics and Chemical Probes for Target Discovery

Improved deconvolution of natural products' protein targets using diagnostic ions from chemical proteomics linkers

Chemical Proteomics: Terra Incognita for Novel Drug Target Profiling

Chemoproteomics: Towards Global Drug Target Profiling

Chemical methods for the proteome-wide identification of posttranslationally modified proteins

Chemical proteomic mapping of reversible small molecule binding sites in native systems

End-to-End Throughput Chemical Proteomics for Photoaffinity Labeling Target Engagement and Deconvolution

Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays

Chemical proteomics accelerates the target discovery of natural products

Profiling Of Post-Translational Modifications By Chemical And Computational Proteomics

[Chemical Proteomics and Discovery of Drug Targets].

Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells

Protein target discovery of drug and its reactive intermediate metabolite by using proteomic strategy